HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.
J Natl Cancer Inst
; 112(1): 46-54, 2020 01 01.
Article
in En
| MEDLINE
| ID: mdl-31037288
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Biomarkers, Tumor
/
Gene Expression
/
Receptor, ErbB-2
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
J Natl Cancer Inst
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: